Family Office ClubEvents
Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com
Menu
DirectoryAll firmsBrowse by countryBrowse by cityBrowse by where they investBrowse by parent industryBrowse by stageMost activeLargest disclosed fundsResearchCompanies backed by the most CVCsMost active corporate investorsFund size ladderDeals per quarterFor FoundersFor Corporate VCsAboutTalk to a humanTell me your situationText (808) 600-9260

Taiho Innovations

Profile, fund size and portfolio

Parent Taiho Pharmaceutical

Taiho Innovations is the corporate venture arm of Taiho Pharmaceutical, a pharmaceutical and biotech company. It invests from seed to Series A. Sectors it names: biotech and life sciences, healthcare and digital health.

Commitment by parentS3
JPY 5bn

Every figure links to its source

Snapshot

Investment stage: Seed to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series A
SectorsBiotech and life sciences, Healthcare and digital health
GeographyAsia

Sources: S1 Taiho Innovations: about.

Graphic 1 of 2

Investment stage: Seed to Series A

Sources: S1 Taiho Innovations: about.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeJPY 5bnCommitment by parentStated by the firm or its parentS3
Companies on the firm's portfolio page4companiesCounted from the firm's own listS2

Sources: S3 LINK-J: Taiho Innovations expands investment frame to JPY 5 billion; S2 Taiho Innovations: investment and incubation.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S3 LINK-J: Taiho Innovations expands investment frame to JPY 5 billion; S2 Taiho Innovations: investment and incubation.

Download:Report a correction

Where it invests

Geography

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyTaiho PharmaceuticalSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Headline sizeJPY 5bn (Commitment by parent)Reported by LINK-J: Taiho Innovations expands investment frame to JPY 5 billionS3
StagesSeed, Series A (inferred from announced rounds)EstimateS1

Portfolio

The firm's portfolio page lists 4 companies.S2

Shared portfolio with other corporate VCs

2 companies on the Taiho Innovations portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
CEJ Capital1GAIA BioMedicine
Higin Capital1StapleBio

Companies backed by the most corporate VCs

Every company on the Taiho Innovations list

4 companies, as listed on the firm's own website.S2 Read the firm's list.

  • GAIA BioMedicine
  • Myrodia
  • StapleBio
  • Totomo Pharma (遠友ファーマ)

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Taiho Innovations: aboutFirm
  2. S2Taiho Innovations: investment and incubationFirm
  3. S3LINK-J: Taiho Innovations expands investment frame to JPY 5 billionThird-party report

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Taiho Innovations or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.

Report a correction